These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9636613)

  • 1. FK506 rescue therapy in lung transplantation.
    Wiebe K; Harringer W; Franke U; Strüber M; Krug N; Korff F; Wahlers T; Cremer J; Haverich A
    Transplant Proc; 1998 Jun; 30(4):1508-9. PubMed ID: 9636613
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis.
    Walker S; Habib S; Rose M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1519-20. PubMed ID: 9636618
    [No Abstract]   [Full Text] [Related]  

  • 3. Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppression.
    Hoffmeyer F; Hoeper MM; Spiekerkötter E; Harringer W; Haverich A; Fabel H; Niedermeyer J
    Transplantation; 2000 Aug; 70(3):522-5. PubMed ID: 10949197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.
    Nair RV; Huang X; Shorthouse R; Adams B; Brazelton T; Braun-Dullaeus R; Morris RE
    Transplant Proc; 1997; 29(1-2):614-5. PubMed ID: 9123154
    [No Abstract]   [Full Text] [Related]  

  • 5. FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.
    Knoop C; Antoine M; Vachiéry JL; Yernault JC; Estenne M
    Transplant Proc; 1994 Dec; 26(6):3240-1. PubMed ID: 7527957
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary rejection diagnosis after lung and heart-lung transplantation.
    Reichenspurner H; Dienemann H; Rihl M; Wagner F; Meiser BM; Kur F; Hammer C; Forst H; Kreuzer E; Reichart B
    Transplant Proc; 1993 Dec; 25(6):3299-300. PubMed ID: 8266550
    [No Abstract]   [Full Text] [Related]  

  • 7. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation.
    Revell MP; Lewis ME; Llewellyn-Jones CG; Wilson IC; Bonser RS
    J Heart Lung Transplant; 2000 Dec; 19(12):1219-23. PubMed ID: 11124493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Schulze C; Fuchs A; Mair H; Reichenspurner H; Kreuzer E; Reichart B
    Transplant Proc; 1997; 29(1-2):605-6. PubMed ID: 9123150
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus-based immunosuppressive protocols in lung transplantation.
    Reichenspurner H; Kur F; Treede H; Meiser BM; Welz A; Vogelmeier C; Schwaiblmeier M; Müller C; Fürst H; Briegel J; Reichart B
    Transplant Proc; 1999; 31(1-2):171-2. PubMed ID: 10083062
    [No Abstract]   [Full Text] [Related]  

  • 11. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.
    Gerbase MW; Spiliopoulos A; Fathi M; Nicod LP
    Transplant Proc; 2001 May; 33(3):2146-7. PubMed ID: 11377481
    [No Abstract]   [Full Text] [Related]  

  • 12. First experience with FK 506 for treatment of chronic pulmonary rejection.
    Reichenspurner H; Meiser BM; Kur F; Wagner F; Welz A; Uberfuhr P; Briegel H; Reichart B
    Transplant Proc; 1995 Jun; 27(3):2009. PubMed ID: 7540775
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation.
    Lipson DA; Palevsky HI; Kotloff RM; Edelman J
    Transplant Proc; 1998 Jun; 30(4):1505-7. PubMed ID: 9636612
    [No Abstract]   [Full Text] [Related]  

  • 14. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
    Celik MR; Lederer DJ; Wilt J; Eser D; Bacchetta M; D'Ovidio F; Sonett JR; Arcasoy SM
    J Heart Lung Transplant; 2009 Jul; 28(7):697-703. PubMed ID: 19560698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans.
    Roman A; Bravo C; Monforte V; Reyes L; Canela M; Morell F
    Transplant Proc; 2002 Feb; 34(1):146-7. PubMed ID: 11959227
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome.
    Kesten S; Chaparro C; Scavuzzo M; Gutierrez C
    J Heart Lung Transplant; 1997 Sep; 16(9):905-12. PubMed ID: 9322139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation.
    Sarahrudi K; Carretta A; Wisser W; Senbaklavaci O; Ploner M; Neuhauser P; Dobrovits M; Miwai Marta G; Papp A; Klepetko W
    Transpl Int; 2002 Jan; 15(1):24-8. PubMed ID: 11875609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506.
    Ko WJ; Chou NK; Chen YS; Hsu RB; Wang SS; Chu SH
    Transplant Proc; 1998 Nov; 30(7):3339-41. PubMed ID: 9838474
    [No Abstract]   [Full Text] [Related]  

  • 20. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
    J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.